What factors are predictive of survival in patients with non‐small‐cell lung cancer treated with gefitinib?

Podobne zapisy

• Predictive factors associated with prolonged survival in patients with advanced non-small-cell lung cancer (NSCLC) treated with gefitinib
  od: Satouchi, M, i wsp.
  Wydane: (2007)
• New combination therapy improves survival in non‐small cell lung cancer
  od: Aiyappan, Vinod
  Wydane: (2007)
• Adjuvant chemotherapy and survival in completely resected non-small cell lung cancer
  od: Birring, S
  Wydane: (2004)
• Real‐World Data on Prognostic Factors for Overall Survival in EGFR Mutation‐Positive Advanced Non‐Small Cell Lung Cancer Patients Treated with First‐Line Gefitinib
  od: Yao, Zong‐Han, i wsp.
  Wydane: (2017)
• Does oestrogen lead to improved survival in women with non-small cell lung cancer?
  od: Ostberg, J
  Wydane: (2004)